The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Hyperparathyroidism and the Calcium Paradox of Aldosteronism
Abstract
Background— Aldosteronism may account for oxi/nitrosative stress, a proinflammatory phenotype, and wasting in congestive heart failure. We hypothesized that aldosterone/1% NaCl treatment (ALDOST) in rats enhances Ca 2+ and Mg 2+ excretion and leads to systemic effects, including bone loss. Methods and Results— At 1, 2, 4, and 6 weeks of ALDOST, we monitored Ca 2+ and Mg 2+ excretion, ionized [Ca 2+ ] o and [Mg 2+ ] o , parathyroid hormone and α 1 -antiproteinase activity in plasma, bone mineral density, bone strength, Ca 2+ and Mg 2+ content in peripheral blood mononuclear cells (PBMCs) and ventricular tissue, and lymphocyte H 2 O 2 production. A separate group received spironolactone (Spiro), an aldosterone receptor antagonist. Age- and gender-matched unoperated and untreated rats served as controls. ALDOST induced a marked ( P <0.05) and persistent rise in urinary and fecal Ca 2+ and Mg 2+ excretion, a progressive reduction ( P <0.05) in [Ca 2+ ] o and [Mg 2+ ] o , and an elevation in parathyroid hormone ( P <0.05) with a fall ( P <0.05) in bone mineral density and strength. An early, sustained increase ( P <0.05) in PBMC Ca 2+ and Mg 2+ was found, together with an increase ( P <0.05) in tissue Ca 2+ . Plasma α 1 -antiproteinase activity was reduced ( P <0.05), whereas lymphocyte H 2 O 2 production was increased ( P <0.05) at all time points. Spiro cotreatment attenuated ( P <0.05) urinary and fecal Ca 2+ and Mg 2+ excretion, prevented the fall in [Ca 2+ ] o and [Mg 2+ ] o , rescued bone mineral density and strength, and prevented Ca 2+ overloading of PBMCs and cardiomyocytes. Conclusions— In aldosteronism, Ca 2+ and Mg 2+ losses lead to a fall in [Ca 2+ ] o and [Mg 2+ ] o with secondary hyperparathyroidism and bone resorption. Ca 2+ overloading of PBMCs and cardiac tissue leads to oxi/nitrosative stress and a proinflammatory phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Calcium metabolism and parathyroid function in primary aldosteronism
Resnick, L. M., & Laragh, J. H. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90328-6 · Cited by 111
Cited by
Stowasser, M., Sharman, J., Leano, R., Gordon, R. D., Ward, G., Cowley, D., & Marwick, T. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0681 · Cited by 271
Pilz, S., Kienreich, K., Drechsler, C., Ritz, E., Fahrleitner-Pammer, A., Gaksch, M., Meinitzer, A., März, W., Pieber, T. R., & Tomaschitz, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2183 · Cited by 118
Bone involvement in aldosteronism
Salcuni, A. S., Palmieri, S., Carnevale, V., Morelli, V., Battista, C., Guarnieri, V., Guglielmi, G., Desina, G., Eller-Vainicher, C., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1660 · Cited by 101
Primary Hyperparathyroidism With Concurrent Primary Aldosteronism
Maniero, C., Fassina, A., Guzzardo, V., Lenzini, L., Amadori, G., Pelizzo, M. R., Gomez-Sanchez, C., & Rossi, G. P. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173948 · Cited by 94
Laboratory challenges in primary aldosteronism screening and diagnosis
Rehan, M., Raizman, J. E., Cavalier, E., Don-Wauchope, A. C., & Holmes, D. T. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.003 · Cited by 89
Metadata
- Authors
- Chhokar, V. S., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., Myers, L. K., Xing, Z., Smith, R. A., Gerling, I. C., & Weber, K. T.
- Venue
- Circulation
- Published
- 2005-02-22
- Volume
- 111
- Issue
- 7
- Pages
- 871-878
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2094002123
- Cited by
- 208
- References
- 2
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperparathyroidism and the Calcium Paradox of Aldosteronism. https://app.cochat.ai/papers/10.1161/01.cir.0000155621.10213.06
- The paper
- Chhokar, V. S., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., Myers, L. K., Xing, Z., Smith, R. A., Gerling, I. C., & Weber, K. T. (2005). Hyperparathyroidism and the Calcium Paradox of Aldosteronism. Circulation. https://doi.org/10.1161/01.cir.0000155621.10213.06
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.